Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2005 Jan 17;92(1):7-12.
doi: 10.1038/sj.bjc.6602229.

Clinical anticancer drug development: targeting the cyclin-dependent kinases

C Benson  1 , S Kaye, P Workman, M Garrett, M Walton, J de Bono
Affiliations
Review

Clinical anticancer drug development: targeting the cyclin-dependent kinases

C Benson et al. Br J Cancer. .

Abstract

Cell division involves a cyclical biochemical process composed of several step-wise reactions that have to occur once per cell cycle. Dysregulation of cell division is a hallmark of all cancers. Genetic and epigenetic mechanisms frequently result in deranged expression and/or activity of cell-cycle proteins including the cyclins, cyclin-dependent kinases (Cdks), Cdk inhibitors and checkpoint control proteins. The critical nature of these proteins in cell cycling raises hope that targeting them may result in selective cytotoxicity and valuable anticancer activity.

PubMed Disclaimer

References

    1. Aamdal S, Smyth J, Awada A, Dittrich C, Caponigro F, Djurasinovic N, Marchal B, Yule M (2002) Phase II study of E7070 in patients with metastatic melanoma (stage IV). Eur J Cancer 38: S50. - PubMed
    1. Akiyama T, Yoshida T, Tsujita T, Shimizu M, Mizukami T, Okabe M, Akinaga S (1997) G1 phase accumulation induced by UCN-01 is associated with dephosphorylation of Rb and CDK2 proteins as well as induction of CDK inhibitor p21/Cip1/WAF1/Sdi1 in p53-mutated human epidermoid carcinoma A431 cells. Cancer Res 57: 1495–1501 - PubMed
    1. Arguello F, Alexander M, Sterry JA, Tudor G, Smith EM, Kalavar NT, Greene Jr JF, Koss W, Morgan CD, Stinson SF, Siford TJ, Alvord WG, Klabansky RL, Sausville EA (1998) Flavopiridol induces apoptosis of normal lymphoid cells, causes immunosuppression, and has potent antitumor activity in vivo against human leukemia and lymphoma xenografts. Blood 91: 2482–2490 - PubMed
    1. Bennett P, Mani S, O'Reilly S, Wright J, Schilsky RL, Vokes EE, Grochow L (1999) Phase II trial of flavopiridol in metastatic colorectal cancer: preliminary results. Proc Am Soc Clin Oncol 18: 277
    1. Benson C, White J, Twelves C, O'Donnell A, Cruickshank C, Tan S, Gianella-Borradori A, Judson I (2003) A phase I trial of the oral cyclin dependent kinase inhibitor CYC202 in patients with advanced malignancy. Proc Am Soc Clin Oncol 22: 209

MeSH terms

Substances